Table 8.
Univariate analysis |
Multivariate analysis |
|||||
---|---|---|---|---|---|---|
Characteristic | OR | P value | 95% CI | OR | P value | 95% CI |
Sex | ||||||
Men | 1 | |||||
Women | 1.10 | 0.60 | 0.75–1.61 | 1.17 | 0.43 | 0.78–1.75 |
Age | ||||||
<35 years | 1 | |||||
≥35 years | 0.89 | 0.61 | 0.56–1.39 | 1.10 | 0.67 | 0.68–1.78 |
CD4 count | ||||||
<350 cells/mm3 | 1 | |||||
≥350 cells/mm3 | 0.98 | 0.94 | 0.67–1.43 | |||
Previous exposure to ARV | ||||||
No | 1 | |||||
Yes | 4.15 | 0.00 | 2.60–6.62 | 3.30 | 0.00 | 2.04–5.35 |
Length of ARV interruption | ||||||
Missing | 1 | |||||
3–6 months | 3.90 | 0.00 | 2.03–7.49 | |||
>7 months | 4.82 | 0.00 | 2.59–8.95 | |||
Risky health exposure | ||||||
No | 1 | |||||
Yes | 1.70 | 0.32 | 0.59–4.93 | |||
Site | ||||||
Maputo | 1 | |||||
Tete | 2.97 | 0.00 | 1.95–4.51 | 2.52 | 0.00 | 1.63–3.91 |